Jane Nicholls

An epilepsy mutation in the β1 subunit of the voltage-gated sodium channel results in reduced channel sensitivity to phenytoin

Paul T. Lucas, Laurence S. Meadows, Jane Nicholls et al. · Epilepsy Research · 2005 · 67 citations

Natural Sciences, Neuroscience, Pharmacology +17

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

José M. Gatell, Lambert Assoumou, Graeme Moyle et al. · Clinical Infectious Diseases · 2018 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

Ana Gonzalez‐Cordón, Lambert Assoumou, Graeme Moyle et al. · Journal of Antimicrobial Chemotherapy · 2021 · 27 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Evidence of changing sexual behaviours and clinical attendance patterns, alongside increasing diagnoses of STIs in MSM and TPSM

Louis MacGregor, Nathan Speare, Jane Nicholls et al. · Sexually Transmitted Infections · 2021 · 23 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +17

Dual therapy with renally adjusted lamivudine and dolutegravir: a switch strategy to manage comorbidity and toxicity in older, suppressed patients?

Michael Tan, Sarah Johnston, Jane Nicholls et al. · HIV Medicine · 2019 · 20 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17